Back to Search Start Over

IgM-rheumatoid factor as a novel biomarker for a reduced survival in anti-PD-1 treated NSCLC patients through the decrease of CD137+T-cells

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.od......3686..1d07eb3b0fd1f64cf36305fed1aa998f